Articles about COVAXIN

FDA rejects emergency-use approval of Bharat Biotech's COVAXIN

11 Jun 2021

FDA rejects emergency-use approval of Bharat Biotech's COVAXIN

The United States' top drug regulator - the Food and Drug Administration - has rejected Bharat Biotech's application for an emergency use authorization for its COVID-19 vaccine COVAXIN.

10 Jun 2021

After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices

After India's COVID-19 vaccination policy was updated this week, the central government is likely to renegotiate prices for vaccines, a report suggested.

07 Jun 2021

AIIMS-Delhi begins screening children for COVAXIN clinical trials from today

The All India Institute of Medical Sciences (AIIMS), Delhi will begin screening children from Monday to conduct clinical trials of the indigenously developed, Bharat Biotech's vaccine against COVID-19, COVAXIN.

05 Jun 2021

Deck cleared for import of COVAXIN, Sputnik V into Brazil

Brazil has cleared the proposal to import Bharat Biotech's COVID-19 vaccine, COVAXIN, and Russia's COVID-19 vaccine Sputnik V into the South American country.

03 Jun 2021

COVAXIN trials on children aged 2-18 begin at AIIMS-Patna

The All India Institute of Medical Sciences (AIIMS) in Patna has begun the clinical trials for COVAXIN on children, reports say.

29 May 2021

Health Ministry thrashes reports about 'missing' COVAXIN doses

The Health Ministry has slammed news about unaccounted COVAXIN doses as "unfound media reports" adding that these reports are incorrect and not supported by full information on the matter.

28 May 2021

4 crore COVAXIN doses missing? Mismatch in production, availability reported

Even as India is facing an acute vaccine shortage, a report indicates that there is a mismatch in the number of doses of COVAXIN produced and the number of doses administered.

28 May 2021

Bharat Biotech enters contract manufacturing deal for COVAXIN drug substance

Hester Biosciences on Thursday said a memorandum of understanding (MoU) has been signed between Hyderabad-based vaccine maker Bharat Biotech and Gujarat COVID-19 Vaccine Consortium (GCVC) for contract manufacturing the drug substance for COVAXIN.

28 May 2021

Second drive-through vaccination camp inaugurated in Delhi

A two-day drive-through vaccination camp for people in the age group of 18-44 years was inaugurated by Delhi Deputy Chief Minister Manish Sisodia in Saket on Thursday, officials said.

27 May 2021

1st dose Covishield, 2nd dose COVAXIN: Vaccination blunder in UP

In a grave oversight, a group of villagers in Uttar Pradesh received two shots of two different vaccines: COVAXIN and Covishield (both two-dose vaccines).

25 May 2021

Need more information to give EUL to COVAXIN: WHO

The World Health Organization (WHO) has said that more information is required from Bharat Biotech, which is seeking emergency use listing (EUL) for its COVID-19 vaccine COVAXIN.

24 May 2021

COVAXIN trials on children are expected to begin in June

Bharat Biotech, the pharmaceutical firm behind India's first indigenous COVID-19 vaccine COVAXIN, may begin trials on children in June and is expecting to receive the license in the third quarter of this year.

19 May 2021

Karnataka targets vaccinating eligible population by 2021 end

The Karnataka government has set a goal to vaccinate all eligible people in the state by November end against coronavirus.

16 May 2021

COVAXIN, Covishield effective, but produce fewer antibodies against B.1.617: Report

According to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR), COVAXIN and Covishield—vaccines deemed effective at generating an immune response against COVID-19—appear to generate only half as many antibodies against the B.1.617 variant.

13 May 2021

COVAXIN approved for Phase 2/3 trials on 2-18-year-olds

India's apex drug regulator has granted permission for conducting the Phase II/III clinical trial of Bharat Biotech's COVAXIN in the age group of 2 to 18 years, the Union Health Ministry said on Thursday. The trial will be conducted on 525 healthy volunteers.

12 May 2021

Government-owned BIBCOL to produce 2 crore COVAXIN doses every month

To accelerate the production of COVAXIN—the indigenous COVID-19 vaccine developed by Hyderabad-based Bharat Biotech—amid severe vaccine shortage in India, the Centre on Wednesday reportedly gave its nod for production of COVAXIN at government-owned Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh's Bulandshahr.

12 May 2021

Bharat Biotech has refused additional COVAXIN doses to Delhi: Sisodia

Deputy Chief Minister Manish Sisodia on Wednesday said that Hyderabad-based Bharat Biotech has informed the Delhi government that it cannot provide "additional" doses of COVAXIN to the national capital.

12 May 2021

COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel

In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.

10 May 2021

COVAXIN doses unavailable for second consecutive day in Mumbai

Vaccination centers in Mumbai did not administer COVAXIN for the second straight day on Monday because of the lack of stock, leaving citizens fuming as many are due for their second dose of the vaccine.

01 May 2021

Truck laden with COVAXIN abandoned for 12 hours, driver missing

A truck carrying 2.40 lakh doses of COVAXIN worth Rs. 8 crore was left parked for nearly 12 hours after its driver went missing under mysterious circumstances in Madhya Pradesh's Narsinghpur district.

29 Apr 2021

Bharat Biotech reduces COVAXIN price to Rs. 400 for states

Hyderabad-based pharmaceutical company Bharat Biotech on Thursday reduced the price of its COVID-19 vaccine, COVAXIN, for state governments.

28 Apr 2021

Indian vaccine found effective against new COVID-19 variant: Dr. Fauci

COVAXIN, the indigenous coronavirus vaccine, has been found effective against the B.1.617 variant or the Indian "double mutant" strain, White House Chief Medical Adviser and the US' top pandemic expert, Dr. Anthony Fauci has said.

21 Apr 2021

Coronavirus: 0.04% people infected after COVAXIN shot; 0.03% after Covishield

The central government on Wednesday said that a "very small" fraction of people have tested positive for COVID-19 after being vaccinated.

21 Apr 2021

COVAXIN neutralizes double mutant strain: ICMR

Indigenously developed COVID-19 vaccine, COVAXIN, neutralizes multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.

20 Apr 2021

Bharat Biotech to produce 700 million COVAXIN doses per year

To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, COVAXIN, to 700 million doses per annum, the vaccine maker said on Tuesday.

16 Apr 2021

Maharashtra institute gets nod to produce COVAXIN; Thackeray thanks Modi

The Central government has allowed the Maharashtra government-owned Haffkine Institute to manufacture COVAXIN, the coronavirus vaccine developed by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research (ICMR).

08 Apr 2021

PM Modi gets second dose of coronavirus vaccine

On Thursday, Prime Minister Narendra Modi received the second dose of coronavirus vaccine, over a month after he took the first shot.

31 Mar 2021

COVAXIN manufacturing facility fails to meet CGMP standards: Brazilian regulator

The Brazilian health regulator Anvisa denied permission to import Bharat Biotech's COVID-19 vaccine COVAXIN into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing Practice requirements.

23 Mar 2021

COVAXIN, Covishield not linked to increased risk of blood clotting

There is no heightened risk of blood clotting after vaccinations with indigenous COVAXIN and Covishield, the coronavirus vaccine developed by AstraZeneca and the University of Oxford, a top government committee concluded, reports Indian Express.

20 Mar 2021

Protection from COVID-19 vaccine possibly lasts 8-10 months: AIIMS Director

The COVID-19 vaccine should be able to give good protection from the infection for eight to ten months or even more, AIIMS Director Dr. Randeep Guleria said on Saturday.

20 Mar 2021

Nepal gives emergency use approval to Bharat Biotech's COVAXIN

Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's COVAXIN, becoming the third country to approve India's indigenously developed COVID-19 vaccine.

09 Mar 2021

COVAXIN Phase-II trial interim data shows better reactogenicity, safety: Lancet

COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has shown better reactogenicity and safety, Phase II trial interim data published in The Lancet journal showed.

03 Mar 2021

COVAXIN 81% effective, offers protection against UK variant: Bharat Biotech

COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has been found to have 81% interim efficacy against preventing infections, the company said on Wednesday.

01 Mar 2021

PM Modi gets the first shot of coronavirus vaccine

On Monday, Prime Minister Narendra Modi received the first shot of the coronavirus vaccine, just as the campaign to inoculate those above 60 and above 45 with illnesses started nationwide.

27 Feb 2021

Private hospitals to charge for COVID-19 vaccine: Details here

As India prepares to inoculate people above 60 years and those over 45 years with comorbidities against COVID-19 from March 1, the Centre on Friday said private hospitals would charge up to Rs. 100 for vaccine administration.

26 Feb 2021

WHO lauds India for helping over 60 nations with vaccines

The Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus has lauded Prime Minister Narendra Modi's commitment to supporting vaccine equity and sharing COVID-19 vaccines with over 60 countries across the world, hoping that the other nations will follow his example.

25 Feb 2021

Are you eligible for COVID-19 vaccination? Should you get it?

India is scheduled to begin the second phase of its COVID-19 vaccination drive from March 1.

12 Feb 2021

Congress-ruled Chhattisgarh wants COVAXIN supplies halted, Dr. Harsh Vardhan responds

Union Health Minister Dr. Harsh Vardhan has responded to the COVAXIN-related concerns of Chhattisgarh minister TS Singh Deo, saying that both coronavirus vaccines were given emergency use authorization after due diligence and that he should focus on amplifying inoculation in his state.

06 Feb 2021

Twenty-five countries in queue for Made in India COVID-19 vaccine

India has so far supplied the COVID-19 vaccine to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister S Jaishankar said on Saturday.

05 Feb 2021

Expert panel recommended against granting EUA to Pfizer's vaccine: Officials

Just two days before pharma major Pfizer announced the withdrawal of its application for emergency use authorization of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage.


Latest News

Features

Popular timelines

Download App
Stay Updated